GENEVA, May 18 -- ORPHALAN S.A. (226 Boulevard Voltaire75011 Paris) filed a patent application (PCT/EP2025/082288) for "FORMULATION COMPRISING TRIETHYLENETETRAMINE TETRAHYDROCHLORIDE" on Nov 07, 2025. With publication no. WO/2026/099431, the details related to the patent application was published on May 15, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AMIN, Naseem (20 Blenheim RoadLondon NW8 0LX)

Abstract: This invention relates to pharmaceutical formulations comprising triethylenetetramine tetrahydrochloride (TETA.4HCl). Specifically, it relates to pharmaceutical compositions which are ...